Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
12/2012
12/12/2012CN102000052B Application of taxol and taxol derivatives to pharmacy
12/12/2012CN101928234B 6/7-(hetero)aryl-N-hydroxyl hexanamide/heptamide compounds and method for preparing same
12/12/2012CN101925357B Formulas comprising calcium, magnesium, zinc, and vitamin D3 for prevention and amelioration of osteoporosis
12/12/2012CN101919913B Composition with effect of treating rheumatoid arthritis
12/12/2012CN101906069B (S)-2-substituted-(3'-acetyl-2'-pyridone-1'-yl) acetic acid as well as preparation method and application thereof
12/12/2012CN101875648B Method for extracting and purifying Pinostrobin from medicinal plants, and pharmaceutical preparation and application thereof
12/12/2012CN101863876B Fluoroquinolone comprising 7-(3-amino-4-oximido)-1-piperidyl substitutional group and application of composition thereof
12/12/2012CN101835486B Pharmaceutical composition and related methods
12/12/2012CN101829113B Application of berberine in medicine for treating or preventing influenza virus
12/12/2012CN101820869B Method to ameliorate oxidative stress and improve working memory via pterostilbene administration
12/12/2012CN101811974B 4-(3-(dimethoxy) propoxy)-3, 5-dimethoxy benzoic acid, and preparation method and medical purpose thereof
12/12/2012CN101809001B 咪唑衍生物 Imidazole derivatives
12/12/2012CN101801941B Pharmaceutical containing ppar delta agonist
12/12/2012CN101801351B Solid preparation comprising alogliptin and metformin hydrochloride
12/12/2012CN101786979B (+/-)-marinopyrrole A for resisting methicillin-resistant staphylococcus aureus (MRSA) and synthesized derivative thereof
12/12/2012CN101772507B Proteasome inhibitors
12/12/2012CN101757626B Pharmaceutical composition containing insulin-like growth factor-I receptor inhibitor and histon deacetylase (HDAC) inhibitor and application thereof
12/12/2012CN101747226B N-oxalic acid acyl amino acid derivatives and N-oxalic acid acyl dipeptide derivatives as well as applications thereof in preparation of consciousness-promoted drugs
12/12/2012CN101687868B Morphinan compounds
12/12/2012CN101683310B Anthranilic acid amides and the derivatives thereof as cosmetic and pharmaceutical agents
12/12/2012CN101679401B 2-oxo-3-benzyl-benzoxazol-2-one derivatives and related compounds as MET kinase inhibitors for the treatment of tumors
12/12/2012CN101679326B Substituted phenoxy n-alkylated thiazoledinedione as estrogen related receptor-alpha modulators
12/12/2012CN101678014B 杂环激酶调节剂 Heterocycle kinase modulators
12/12/2012CN101665449B Water-soluble prodrug of tamibarotene, and preparation method and applications thereof
12/12/2012CN101631791B Substituted spirochromanone derivatives as ACC inhibitors
12/12/2012CN101610775B Analgesic agent comprising cyclic phosphatidic acid derivative
12/12/2012CN101594868B A pharmaceutical composition having antipsychotic, antidepressant or antiepiieptic activity with reduced side effect
12/12/2012CN101563317B O-substituted-dibenzyl urea-derivatives as trpv1 receptor antagonists
12/12/2012CN101528204B Controlled release complex composition comprising angiotensin-ii-receptor blockers and hmg-coa reductase inhibitors
12/12/2012CN101525364B Crystal form of fulvestrant and preparation method thereof
12/12/2012CN101524363B Artificial saliva
12/12/2012CN101511813B Heterocyclic FXR binding compounds
12/12/2012CN101492456B Coumarin ether compounds and new use of composition
12/12/2012CN101486677B 5HT2C receptor modulators
12/12/2012CN101480385B Use of methionine
12/12/2012CN101466693B Piperidine derivatives as human papilloma virus inhibitors
12/12/2012CN101415716B Condensed imidazole derivatives as aldosterone synthase inhibitors
12/12/2012CN101410111B Useful combinations of monobactam antibiotics with beta-lactamase inhibitors
12/12/2012CN101384568B Novel acetyl-coa carboxylase (acc) inhibitors and their use in diabetes, obesity and metabolic syndrome
12/12/2012CN101370803B Substituted indolyl-alkyl-amino-derivatives as inhibitors of histone deacetylase
12/12/2012CN101365708B Crystalline forms of 1-benzoyl-4-[2-[4-methoxy-7-(3-methyl-1h-1,2,4-triazol-1-yl)-1-[(phosphonooxy)methyl]-1h-pyrrolo[2,3-c]pyridin-3-yl]-1,2-dioxoethyl]-piperazine
12/12/2012CN101340910B Treatment of drug-resistant tumors
12/12/2012CN101340894B Bursting pellets
12/12/2012CN101332193B Preparation method of fluvoxamine maleate medicine composition
12/12/2012CN101312746B Preparation containing iron(iii)-complexes and redox substances
12/12/2012CN101282714B Ophthalmic emulsions containing prostaglandins
12/12/2012CN101253168B Substituted benzimidazoles as kinase inhibitors
12/12/2012CN101239989B Nucleotide analog
12/12/2012CN101228152B N-(heteroaryl)-1-heteroarylalkyl-1h-indole-2-carboxamide derivatives, preparation and therapeutic use thereof
12/12/2012CN101223150B Polymorphic forms of (s)-1-cyanobutan-2-yl (s)-1-(3-(3-(3-methoxy-4-(oxazol-5-yl) phenyl) ureido) phenyl) ethylcarbamate
12/12/2012CN101180290B Hydogrenated benzo[c] thiophene derivatives as immunomodulators
12/12/2012CN101175503B Composition and method for regulating and remaining vaginal flora and vaginal acidity be normal
12/12/2012CN101137624B Compounds for inflammation and immune-related uses
12/12/2012CN101057885B Medicinal composition for treating osteoporosis and preparations and application thereof
12/12/2012CN101043898B The use of winter savory(satureja montana) or the extracts thereof for the preparation of medicaments for the treatment of the premature ejaculation
12/11/2012USRE43858 Substituted cycloalkene derivative
12/11/2012US8330026 Derivatives of the NF-κB inducing enzyme, their preparation and use
12/11/2012US8329993 Delta 6 desaturases from primulaceae, expressing plants and PUFA-containing oils
12/11/2012US8329946 Histone deacetylases, and uses related thereto
12/11/2012US8329945 Histone deacetylases, and uses related thereto
12/11/2012US8329928 Compounds, compositions and methods
12/11/2012US8329924 Compounds and methods for the treatment or prevention of Flavivirus infections
12/11/2012US8329922 Crystalline sodium atorvastatin
12/11/2012US8329919 Salt hydrates
12/11/2012US8329918 Selective alpha 2B/2C agonists
12/11/2012US8329916 Human protein tyrosine phosphatase inhibitors and method of use
12/11/2012US8329914 Cyclic benzimidazole derivatives useful as anti-diabetic agents
12/11/2012US8329911 Biphenyl compounds useful as muscarinic receptor antagonists
12/11/2012US8329908 Dual action antibiotics
12/11/2012US8329906 Guanidinyl-substituted hydroxy-6-phenylphenanthridines
12/11/2012US8329900 Immunosuppressants; autoimmune disease; antiinflammatory agents; multiple sclerosis; rheumatic diseases; antiarthritic agents; aids; preparing, for example, 2-{6-[3-Amino-piperidin-1-yl]-3-ethyl-2,4-dioxo-3,4-dihydro-2H-pyrimidin-1-ylmethyl}-benzonitrile
12/11/2012US8329761 Oil-in-oil emulsions
12/11/2012US8329760 Pharmaceutical composition
12/11/2012US8329758 Preparing hand antiseptics having a high alcohol concentration (>60%) by neutralizing an aqueous dispersion of a carbopol" polymer by an hydroxide of sodium, potassium, ammonium or magnesium to effect gelation and obtain a gel of 4.1-4.8 pH; adding ethanol; microbiocides; bactericides; nontoxic (GRAS)
12/11/2012US8329757 Curcumin analog compositions and related methods
12/11/2012US8329756 Drug for treatment of colon cancer
12/11/2012US8329755 Methods for treating retroviral infections
12/11/2012US8329754 Squaramide derivatives as CXCR2 antagonist
12/11/2012US8329753 Combination of compounds, or a bifunctional compound, that provides fatty acid metabolism and glycolysis inhibition
12/11/2012US8329752 Composition for administering an NMDA receptor antagonist to a subject
12/11/2012US8329751 Compounds having aryl-sulphonamidic structure useful as metalloproteases inhibitors
12/11/2012US8329750 Methods for treating vasomotor symptoms using GABA analogs in a gastric retentive dosage form
12/11/2012US8329749 Use of (−) (3-trihalomethylphenoxy) (4-halophenyl) acetic acid derivatives for treatment of hyperuricemia
12/11/2012US8329748 Biologically active oils
12/11/2012US8329747 Polyunsaturated fatty acid monoglycerides, derivatives, and uses thereof
12/11/2012US8329746 Method for treating osteoarthritis
12/11/2012US8329745 Small molecule inhibitors of ghrelin O-acyltransferase
12/11/2012US8329743 Compositions and its use in treating obesity or inducing weight loss
12/11/2012US8329742 Macrocyclic compounds useful as pharmaceuticals
12/11/2012US8329741 Substituted pyrrolidine compounds with central nervous system activity
12/11/2012US8329740 Polymorphs of sunitinib malate
12/11/2012US8329739 Phenylimidazole compounds
12/11/2012US8329738 Use of AMPK-activating imidazole derivatives, preparation process therefor and pharmaceutical compositions comprising them
12/11/2012US8329737 Benzimidazoles as selective kinase inhibitors
12/11/2012US8329736 Triazole compounds that modulate HSP90 activity
12/11/2012US8329735 Tetrazole compounds which selectively modulate the CB2 receptor
12/11/2012US8329734 Topical therapy for migraine
12/11/2012US8329732 Kinase inhibitors and methods of their use
12/11/2012US8329731 PTEN inhibitor or Maxi-K channels opener
12/11/2012US8329730 Compounds
1 ... 922 923 924 925 926 927 928 929 930 931 932 933 934 935 936 937 938 939 940 941 942 ... 7860